pdufa.bio
HomeReadouts › April 2027

April 2027 clinical-trial readouts

Updated ยทnext FDA decision on the calendar
trial-readout estimates for April 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← March 2027May 2027 →
13 readouts
CGTX · Apr 2027 (est.)
Dextromethorphan-Bupropion: Early Alzheimer's Disease
Awaiting dataupdated 9mo ago
KPTI · Apr 2027 (est.)
Selinexor: Multiple Myeloma
Awaiting data
KYTX · Apr 2027 (est.)
Standard of Care Treatment: Multiple Sclerosis, Primary Progressive
Awaiting dataupdated 18mo ago
MNOV · Apr 2027 (est.)
MN-166: Amyotrophic Lateral Sclerosis
Awaiting dataupdated 4mo ago
SMMT · Apr 2027 (est.)
Ivonescimab: Endometrial Cancer
CLDX · Apr 2027 (est.)
Barzolvolimab: Malignant Epithelial Neoplasms
Awaiting data
TLX · Apr 2027 (est.)
177Lu-TLX591: Bone Pain
IOVA · Apr 2027 (est.)
Lifileucel plus Pembrolizumab: Bone Sarcoma
Awaiting data
IDYA · Apr 2027 (est.)
Darovasertib: Uveal Melanoma
Awaiting data
NBTX · Apr 2027 (est.)
NBTXR3: Radiotherapy
Awaiting dataupdated 8mo ago
NVS · Apr 2027 (est.)
Iptacopan: Generalized Myasthenia Gravis
REGN · Apr 2027 (est.)
Cemiplimab: Colon Cancer
AIM · Apr 2027 (est.)
Ampligen: Prostate Adenocarcinoma
Awaiting data
Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).